Description
IGF::OT::IGF TPN BAGS
First action · last action
2016-04-29 · 2017-12-06
Transactions
2
First transaction's obligation
$166,075
Base + all options value (sum of deltas)
$105,770
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA24816D0104
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-04-29+$166,075= $166,075
- Mod P000022017-12-06-$60,305= $105,770
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-04-29 | +$166,075 | $166,075 | IGF::OT::IGF TPN BAGS |
| Mod P00002· FUNDING ONLY ACTION | 2017-12-06 | −$60,305 | $105,770 | IGF::OT::IGF TPN BAGS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NDPWXJSVYVH9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026N0733 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q517 · PHARMACY SERVICES | $89,282 | FY2026 |
| 36C26226N0872 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $164,265 | FY2026 |
| 36C26226N0870 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $167,369 | FY2026 |
| 36C26226N0873 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $140,823 | FY2026 |
| 36C26226N0871 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $231,746 | FY2026 |
| 36C24826P0477 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $26,837 | FY2026 |
Other recipients under 6505 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826F0207 | CSL BEHRING L.L.C. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $183,903 | FY2026 |
| 36C24826P1108 | ASD SPECIALTY HEALTHCARE, LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $54,600 | FY2026 |
| 36C24826P1090 | SIRTEX MEDICAL INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $45,825 | FY2026 |
| 36C24826N0511 | BIOMERIEUX INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $61,788 | FY2026 |
| 36C24826N0693 | MEDI-PHYSICS, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $111,150 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24816J1738_3600_VA24816D0104_3600 · retrieved 2026-09-26.